StockData
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. (VYGR) stock

VYGRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3055% below fair value
$1.63−0.10 (-5.78%)

Close on Nov 16, 2026Market cap $100.44MP/E –Yield –

Voyager Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Voyager Therapeutics

Voyager Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Voyager Therapeutics figures

See a number that looks wrong?